PPBT

Purple Biotech
PPBT

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $4.09M invested in Purple Biotech in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

22% less capital invested

Capital invested by funds: $5.27M → $4.09M (-$1.18M)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$793K
Puts
$702K
Net Calls
Net Calls Change

Top Buyers

1
+$134K
2
+$3.89K

Top Sellers

1
-$286K
2
-$149K
3
-$96K
4
UBS Group
UBS Group
Switzerland
-$4K
5
Morgan Stanley
Morgan Stanley
New York
-$544
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.58M
2
$1.09M
3
$134K
4
$91K
5
$64K
6
$49K
7
$43K
8
$31K
9
$12K
10
$1K
11
–